MSM Product on Attenuating Nasal Provocation With a Standardized Allergenic Challenge
Launched by MEDICUS RESEARCH, LLC · Jan 14, 2015
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
Allergic rhinitis, or nasal allergy, is a common condition throughout the world which affects both adult and children alike. It is a group of symptoms characterized by red, itchy eyes, a blocked, itching, runny nose, rhinorrhea, and sneezing. Other reported symptoms include throat clearing, headaches, facial pain, ear pain, itchy throat and palate, snoring, and sleep disturbances. Nasal allergy commonly occurs when an individual's immune system reacts to allergens such as grass, weed, or tree pollens, house dust, mites, mold, and animal dander \[1, 2\].
Allergic rhinitis is considered to h...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy volunteers ≥ 18 and ≤ 65 years of age
- • Subjects with history of nasal congestion in response to pollen, dust mites, cat dander, and/or dog dander
- • Subjects who score "moderate" or "severe" on the VAS Nasal Symptom Score in response to an allergenic challenge at screening (V1)
- • Judged by the Investigator to be in general good health on the basis of medical history
- Exclusion Criteria:
- • Pregnant and/or lactating women
- • Subjects with idiopathic rhinitis, atrophic rhinitis, or rhinitis medicamentosa
About Medicus Research, Llc
Medicus Research, LLC is a leading clinical research organization dedicated to advancing medical innovation through comprehensive clinical trial management and consulting services. With a focus on enhancing patient care and accelerating the development of new therapies, Medicus Research collaborates with pharmaceutical and biotechnology companies to design and execute clinical studies across various therapeutic areas. The organization emphasizes a patient-centered approach, leveraging a skilled team of professionals and state-of-the-art technology to ensure the highest standards of quality, compliance, and efficiency in trial operations. Through its commitment to scientific integrity and collaboration, Medicus Research plays a vital role in bringing groundbreaking treatments from the lab to the market.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials